Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

342
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
342
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

371
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
371

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease burden estimates in economic evaluation studies of Respiratory Syncytial Virus (RSV) maternal immunization: a systematic review protocol.

Systematic reviews·2026
Same author

Exploring pathways between residential greenness and antepartum stillbirth: A mediation analysis.

Environmental epidemiology (Philadelphia, Pa.)·2026
Same author

Maternal RSV vaccination to protect infants in Brazil: a model-based cost-effectiveness analysis for incorporation into the National Immunisation Program.

Lancet regional health. Americas·2026
Same author

Factors associated with stillbirth in São Paulo, Brazil: FetRiskS - a multidisciplinary case-control study.

BMC pregnancy and childbirth·2025
Same author

Correction: Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.

PLoS neglected tropical diseases·2025
Same author

Discrepancy between official records of the Brazilian National Immunization Program Information System and the household survey about vaccination coverage in Cubatão, São Paulo: cross-sectional study, 2023.

Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil·2025

Related Experiment Video

Updated: Mar 15, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K

Evaluation of Reference Centers for Special Immunobiologicals implementation.

Laura Andrade Lagôa Nóbrega1, Hillegonda Maria Dutilh Novaes2, Ana Marli Christovam Sartori1

  • 1Departamento de Moléstias Infecciosas e Parasitárias. Faculdade de Medicina. Universidade de São Paulo. São Paulo, SP, Brasil.

Revista De Saude Publica
|September 7, 2016
PubMed
Summary

This study evaluated the implementation of Reference Centers for Special Immunobiologicals (CRIEs) in Brazil. Findings revealed diverse service profiles, with some centers fully implemented and others only partially or not at all, highlighting areas for improvement.

More Related Videos

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

1.2K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K

Related Experiment Videos

Last Updated: Mar 15, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

1.2K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K

Area of Science:

  • Public Health
  • Immunization Programs
  • Healthcare Services Evaluation

Background:

  • Reference Centers for Special Immunobiologicals (CRIEs) are crucial for managing and distributing specialized immunobiologicals.
  • Assessing the implementation status of these centers against formal regulations is essential for optimizing their services.

Purpose of the Study:

  • To describe the structure, human resources, and activities of CRIEs.
  • To evaluate the implementation of CRIEs based on formal regulations.

Main Methods:

  • Program evaluation using a descriptive approach.
  • A questionnaire was administered to 42 CRIEs nationwide between August 2011 and January 2012.
  • Data analysis included descriptive statistics and cluster analysis to identify service profiles.

Main Results:

  • Significant diversity was observed across CRIEs in terms of structure, human resources, and activities.
  • Five distinct service profiles were identified: 'Best structure' (12 centers), 'Immunobiologicals distributor' (6 centers), 'Incipient implementation' (5 centers), 'Vaccination rooms' (13 centers), and 'Teaching and research' (6 centers).
  • Implementation status varied, with 'Best structure' and 'Teaching and research' centers deemed fully implemented, 'Immunobiologicals distributor' and 'Vaccination rooms' partially implemented, and 'Incipient implementation' centers not implemented.

Conclusions:

  • The evaluation identified varying levels of implementation among CRIEs, categorized into five profiles.
  • Centers with 'Best structure' and 'Teaching and research' profiles meet regulatory standards.
  • Partially and non-implemented centers require strategic reformulation to align with current healthcare contexts and regulations.